Board of directors

Staffan Encrantz, Chairman – Mr. Encrantz is the Chairman and CEO of Allegro Investment Inc. and represents the owner of AnaMar. He is a private investor who has led the growth and development of a number of early stage businesses to highly successful realizations.

Anders Ekblom, MD, PhD, DDS, Associate Professor – Dr. Ekblom has substantial experience from senior positions in the biopharmaceutical industry. He has been the executive vice president of Global Medicines Development at AstraZeneca, and the CEO of AstraZeneca Sweden AB. Currently, he is a board member of a number of life science companies.

Marie Carlsson – Mrs. Carlsson is the VP and CFO of Allegro Investment Inc., the Investment Manager of the owner of AnaMar. She has been working in the Allegro group since 2004 and is mainly responsible for financing, accounting and administration. Before Allegro, she spent 7 years in accounting at a semiconductor in Silicon Valley.

Ulf Ljungberg, PhD, CEO – Dr. Ljungberg joined AnaMar in October 2015 as Chief Executive Officer. He has long experience from Life science in executive management, licensing/business development and marketing/sales positions in various countries in big pharma and as CEO of biotech start-ups.